363 related articles for article (PubMed ID: 29661626)
1. Influence of an independent quarterly audit on publicly reported vancomycin-resistant enterocococi bacteremia data in Ontario, Canada.
Prematunge C; Policarpio ME; Johnstone J; Adomako K; Nadolny E; Lam F; Li Y; Brown KA; Garber G
Am J Infect Control; 2018 Sep; 46(9):1036-1040. PubMed ID: 29661626
[TBL] [Abstract][Full Text] [Related]
2. Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada.
Johnstone J; Chen C; Rosella L; Adomako K; Policarpio ME; Lam F; Prematunge C; Garber G;
Am J Infect Control; 2018 Nov; 46(11):1266-1271. PubMed ID: 29903421
[TBL] [Abstract][Full Text] [Related]
3. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.
Mac S; Fitzpatrick T; Johnstone J; Sander B
Antimicrob Resist Infect Control; 2019; 8():168. PubMed ID: 31687132
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Multicenter Analysis of Outcomes After Cessation of Control Measures for Vancomycin-Resistant Enterococci.
Lemieux C; Gardam M; Evans G; John M; Suh KN; vanWalraven C; Vicencio E; Coulby C; Roth V; Hota S
Infect Control Hosp Epidemiol; 2017 Jan; 38(1):24-30. PubMed ID: 27804901
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.
Popiel KY; Miller MA
Infect Control Hosp Epidemiol; 2014 Jul; 35(7):818-25. PubMed ID: 24915209
[TBL] [Abstract][Full Text] [Related]
7. Impact of vancomycin-resistant enterococci colonization in critically ill pediatric patients.
Sutcu M; Akturk H; Acar M; Salman N; Aydın D; Akgun Karapınar B; Ozdemir A; Cihan R; Citak A; Somer A
Am J Infect Control; 2016 May; 44(5):515-9. PubMed ID: 26781220
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
Gedik H; Yıldırmak T; Simşek F; Kantürk A; Arıca D; Aydın D; Yokuş O; Demirel N; Arabacı C
J Infect Dev Ctries; 2014 Sep; 8(9):1113-8. PubMed ID: 25212075
[TBL] [Abstract][Full Text] [Related]
9. Validation of healthcare-associated infection surveillance in smaller Australian hospitals.
Hoskins AJ; Worth LJ; Imam N; Johnson SA; Bull AL; Richards MJ; Bennett NJ
J Hosp Infect; 2018 May; 99(1):85-88. PubMed ID: 29031863
[TBL] [Abstract][Full Text] [Related]
10. Laboratory-identified vancomycin-resistant enterococci bacteremia incidence: A standardized infection ratio prediction model.
Tanwar SSS; Weiner-Lastinger LM; Bell JM; Allen-Bridson K; Bagchi S; Dudeck MA; Edwards JR
Infect Control Hosp Epidemiol; 2022 Jun; 43(6):714-718. PubMed ID: 34085620
[TBL] [Abstract][Full Text] [Related]
11. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
Salgado CD
Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
[TBL] [Abstract][Full Text] [Related]
12. Discontinuing Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) Is Associated With Rising VRE Bloodstream Infection Rates in Ontario Hospitals, 2009-2018: A Quasi-experimental Study.
Johnstone J; Shing E; Saedi A; Adomako K; Li Y; Brown KA; Garber G
Clin Infect Dis; 2020 Oct; 71(7):1756-1759. PubMed ID: 31922536
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
[TBL] [Abstract][Full Text] [Related]
14. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation.
Bryce E; Grant J; Scharf S; Dempster L; Lau TT; Laing F; Shajari S; Forrester L
Am J Infect Control; 2015 Nov; 43(11):1238-43. PubMed ID: 26190379
[TBL] [Abstract][Full Text] [Related]
15. Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci.
da Silva NS; Muniz VD; Estofolete CF; Furtado GH; Rubio FG
Am J Infect Control; 2014 Apr; 42(4):389-92. PubMed ID: 24679566
[TBL] [Abstract][Full Text] [Related]
16. Has improved hand hygiene compliance reduced the risk of hospital-acquired infections among hospitalized patients in Ontario? Analysis of publicly reported patient safety data from 2008 to 2011.
DiDiodato G
Infect Control Hosp Epidemiol; 2013 Jun; 34(6):605-10. PubMed ID: 23651891
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.
Puchter L; Chaberny IF; Schwab F; Vonberg RP; Bange FC; Ebadi E
Antimicrob Resist Infect Control; 2018; 7():1. PubMed ID: 29312658
[TBL] [Abstract][Full Text] [Related]
18. The impact of vancomycin-resistant
Cho SY; Kim HM; Chung DR; Choi JR; Lee MA; Huh HJ; Lee NY; Huh K; Kang CI; Peck KR
Infect Control Hosp Epidemiol; 2022 May; 43(5):603-608. PubMed ID: 33993892
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
Zaas AK; Song X; Tucker P; Perl TM
Clin Infect Dis; 2002 Nov; 35(10):1139-46. PubMed ID: 12410472
[TBL] [Abstract][Full Text] [Related]
20. Reporting of vancomycin-resistant enterococci in Connecticut: implementation and validation of a state-based surveillance system.
Dembek ZF; Kellerman SE; Ganley L; Capacchione CM; Tenover FC; Cartter ML; Van Kruiningen HJ; Jarvis WR; Hadler JL
Infect Control Hosp Epidemiol; 1999 Oct; 20(10):671-5. PubMed ID: 10530644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
